Shared decision-making in addiction treatment is a collaborative process in which the patient and clinician make treatment decisions together using the best available evidence and the patient’s goals, values, preferences, and circumstances. The clinician contributes medical and clinical expertise; the patient contributes lived experience and what matters most in daily life.
What happens during shared decision-making?
The clinician explains the decision that needs to be made, describes reasonable options, reviews benefits and risks, checks understanding, and asks about the patient’s priorities. The patient can ask questions, describe concerns, and explain which trade-offs matter most before the plan is chosen.
Why is shared decision-making important in addiction treatment?
Addiction treatment often involves choices rather than one universally correct path. Decisions may involve medications, level of care, therapy approaches, recovery supports, family involvement, or how to address co-occurring mental health conditions.
SAMHSA recommends patient-centered decision-making and shared decision-making as core elements of effective substance use disorder treatment planning.
Does shared decision-making mean the patient chooses any treatment they want?
No. Clinicians still have a responsibility to recommend safe, evidence-based options and explain when a requested treatment is medically inappropriate or outside the program’s capabilities. Shared decision-making occurs within the range of clinically reasonable choices.
How is this different from informed consent?
Informed consent focuses on making sure the patient understands a proposed intervention and its risks, benefits, and alternatives before agreeing. Shared decision-making is broader and emphasizes comparing options together and incorporating the patient’s preferences into the choice.
Can shared decision-making involve medications for addiction?
Yes. Medication decisions can include discussion of expected benefits, side effects, dosing considerations, prior experiences, treatment goals, and alternatives. SAMHSA specifically identifies shared decision-making as an important principle in medication-related behavioral health care.
What if I disagree with the treatment team?
Ask what evidence and safety concerns are driving the recommendation, explain your priorities, and ask whether other reasonable options exist. Disagreement can reveal information that improves the plan, such as work obligations, transportation, medication concerns, family responsibilities, or previous treatment experiences.
How does measurement-based care support shared decisions?
Repeated outcome measures can give both patient and clinician clearer information about whether symptoms, cravings, functioning, or treatment response are changing. See Trinity’s guide to measurement-based care in addiction treatment.
Can family be involved?
Yes, when the adult patient wants that involvement and it is clinically appropriate. The patient’s preferences and privacy rights remain central.
Frequently asked questions
Can I ask for time to think about a treatment decision?
Often, yes, unless an urgent safety issue requires immediate action. Ask what decision deadline exists and why.
Can I decline a recommended option?
Adults with decision-making capacity can generally participate in or decline treatment options, subject to limited legal and emergency exceptions. The clinician should explain the potential consequences and alternatives.
Does shared decision-making apply to level of care?
Patient preferences matter, but safety and clinical need also matter. The selected level should be one that can appropriately manage the assessed risks.
Does Trinity Behavioral Health use a formal shared decision-making model?
Current Trinity-specific treatment-planning practices should be confirmed directly with the adult clinical team.
Authoritative sources
- AHRQ: About Shared Decision Making
- AHRQ: The SHARE Approach
- SAMHSA: Patient-Centered and Shared Decision-Making in SUD Treatment
Shared decision-making is not about shifting responsibility to the patient. It is about combining clinical evidence with the patient’s priorities so treatment decisions are informed, realistic, and person-centered.